Keywords: merck, co, stands, vioxx, article, after, corrected

Merck & Co stands by Vioxx article, after corrected analysis shows no delay in CV risk

Article | 03 July 2006

Print This

US drug major Merck & Co says that it stands behind the original results of the APPROVe study, even though a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in